International Summit on
GMP,GCP,QA,QC and Validation
December 3-5, 2012 DoubleTree by Hilton Philadelphia Center City, USA
Quality Control-2012

    Live Chat
    Participants List in Academia
    Untitled Document
    University of Texas at Arlington, USA

    Stanford University School of Medicine, USA

    Mahidol University, Thailand

    Amirkabir University of Technology, Iran

    Hamdard University, India

    Yeshiva University, USA

    University of Macau, China

    Monash University, Australia

    University of Michigan, Ann Arbor

    Universidade Federal do Rio de Janeiro, Brazil

    University of Denver, Colorado

    University of Toronto, Canada

    Zagazig University, Egypt

    Banaras Hindu University, India

    Taipei Medical University, Taiwan

    University di Messina CNISM, Italy

    University of Tasmania, Australia

    Huazhong University of Science and Technology, China

    Sogang University, Korea

    University of Edinburgh, UK

    Martin-Luther-University Halle-Wittenberg, USA

    Universidade de Sao Paulo, Brazil

    Eve University, Turkey

    University of Delhi, India

    Isfahan University of Technology(IUT), Iran

    Taif University, Saudi Arabia

    University Medical Center, Netherlands

    University of Copenhagen, Denmark

    University Paris 13, France

    Participants List From Business
    Untitled Document
    Cadila Pharmaceuticals, India

    Chemical Works of Gedeon Richter, Hungary

    3S-Pharmacological Consultation & Research GmbH, Germany

    Royal Brisbane and Women's Hospital, Australia

    Psoriasis and Cutaneous Inflammation Research Laboratory, USA

    Alcon Laboratories Inc., USA

    National Institute for Materials Science (NIMS), Japan

    Grup de Recerca de Reumatologia (IRHVH), Spain

    Bayer Health Care, Richmond, USA

    Crown Bioscience Inc., China

    Hammersmith Hospital, London

    Van Drie Research LLC, USA

    Dr.Reddy's labs, India

    Merck Research Laboratories, USA

    National Institute of Pharmaceutical Education and Research (NIPER), India

    AstraZeneca R&D Boston, USA

    Abbott Laboratories, USA

    Hutchison MediPharma Limited, China

    Sage Bionetworks, USA

    Central Drug Research Institute, India

    Glenmark Pharmaceuticals, India

    National Institute for Interdisciplinary Science & Technology (NIIST) , India

    Novartis Campus, Austria

    Upcoming Conferences
    Day 1
    Scientific Program
      Day 2
    Scientific Program
      Day 3
    Scientific Program
    International Conference on QA, QC and Validation paves path for accelerating scientific discoveries with the theme of "New challenges and opportunities in QA, QC and Validation process."

    Quality Control-2012 comprised of 10 tracks and 43 sessions designed to offer comprehensive sessions that address current issues in QA, QC and Validation.

    Submit your Abstract to any of the following Tracks. All related Abstracts are accepted.

    Register now for the conference by choosing an appropriate package suitable to you.
    Abstract Submission   Register
    Renowned Speakers
    speaker Pal Mayasandra
    scientist/chemist Food & Drug Administration, USA

    speaker Jose Zayas
    Nuclear Pharmacy Services, USA

    speaker Linda Biava
    Regulatory Compliance Associates
    Kenosha., USA

    speaker Myriam Ochart
    O-CHART Management Consultants
    FL, USA

    speaker Joseph J. Biehl
    Consulting Services
    ProPharma Group, USA

    speaker Robert Beall
    AD ProPharma Group
    , USA

    speaker Cynitha J
    Lean Compliance Partners
    FL, USA

    speaker Christopher Joseph Devine
    President & CEO
    Devine Guidance International Inc., USA

    speaker Ravi
    General Manager
    BioSPEQ Inc., USA

    speaker Tina
    Gerson Lehrman Group, USA

    speaker Philip Onigman
    Bio-technology Consultant
    Boston, USA

    speaker Kaitlin Bratlie
    Chemical & Biological Engineering
    Iowa state University, USA

    speaker Michel N. Mifundu
    Kyoto University, Japan

    speaker Elizabeth N De Gaspari
    Prof Advisor of Biotechnology program
    Sao Paulo University, Brazil

    speaker Igho Onakpoya
    University of Oxford, UK

    speaker Fernando Geijo Caballero
    Development Team Consulting
    Barcelona, Spain

    speaker vijaya shinde
    Director of Sai Pharmaceutical consultant
    , India

    speaker Rajinsh Gupta
    Research Officer
    Center for Advance research and Development, India

    speaker Prashant G
    Piramal Healthcare Limited
    Mumbai, India

    speaker Divya kanwar Bhati,
    Indian Institute Of Health Management Research, , India

    speaker Tianchang Zuo
    NNE Pharmaplan, Tianjin, China

    speaker Eyob
    lecturer of Pharmacology
    Debre Birhan University , Ethiopia

    Track 1: Quality Control Audit's in Clinical Laboratories
    Track 1-1 Clinical research and phases of research
    Track 1-2 Digitizing in quality control, inspection & reverse engineering
    Track 1-3 Pharmacovigilance
    Track 1-4 Pharmacokinetics and Pharmacoepidemiology
    Track 2: Drug Design and Drug Manufacturer Precautions
    Track 2-1 Drug safety communication
    Track 2-2 Formulations & validation of drugs
    Track 2-3 Medicinal chemistry in drug development
    Track 2-4 Drug safety strategies to the risk compounds
    Track 2-5 Lyophilization process development for proteins
    Track 3: GLP & GMP
    Track 3-1 OECD guidelines for testing of chemicals
    Track 3-2 FDA / EU guidelines
    Track 3-3 Verification and Validation
    Track 3-4 Current Good Manufacturing Practice (cGMP)
    Track 4: Clinical Data Management
    Track 4-1 Validation of rules and regulations
    Track 4-2 Patent rights of drugs
    Track 4-3 Risk assessment of drugs
    Track 4-4 Stability indicating method validation
    Track 5: Analytical Method Development and Validation for Therapeutic Proteins
    Track 5-1 Validation of HPLC methods in pharmaceutical analysis
    Track 5-2 Analytical technologies for biopharmaceutical development
    Track 5-3 Application of QbD and DOE in method development and validation
    Track 5-4 Manufacturing process for therapeutic proteins
    Track 5-5 Six sigma applications in method validation
    Track 6: International Perspectives on Quality Assurance and New Techniques
    Track 6-1 Successful method transfer strategies
    Track 6-2 Socioeconomic impact on advanced technologies
    Track 6-3 NMR spectroscopy and hyphenated technology
    Track 6-4 Quality control in radiochemical analysis
    Track 6-5 Next generation sequencing technology
    Track 7: Novel Methods of Purification by Downstream Processing
    Track 7-1 Designing & development in medical devices
    Track 7-2 Bio- Analytical methods
    Track 7-3 Methods of recovery and purification
    Track 7-4 Vaccine and antibody production
    Track 8: Food and Nutraceuticals
    Track 8-1 Quality control in a typical food processing system
    Track 8-2 Food inspectorate, analytical services, and compliance unit
    Track 8-3 Hazard analysis and critical control points (HACCP)
    Track 8-4 Food law and accompanying regulations
    Track 9: Technology Transfer for Industrial pharmaceuticals
    Track 9-1 Recombinant protein & complex biologic development & production
    Track 9-2 Pharmaceutical quality management software systems
    Track 9-3 Master control validation services
    Track 9-4 Interfacing analytics with process development and formulations
    Track 10: Quality Management and Quality Improvement in Research
    Track 10-1 Identifying and controlling critical quality attributes
    Track 10-2 Quality assessment and validation of computerized systems in clinical trials
    Track 10-3 QA and compliance-audits and inspections
    Track 10-4 Quality improvement in human research protection programs
    Quality Assurance Conferences, Quality Control Meeting 2012
    Conference Secretariat: QA, QC and Validation OMICS Group Conferences
    5716 Corsa Ave., Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
    Phone: +1-650-268-9744 l Fax: +1-650-618-1414
    Toll free: 1-800-216-6499(USA & Canada) l 1-800-651-097(Australia)
    E-mail: qualitycontrol2012@omicsonline.com
    Operated by: Editors - Journal of Outlook on Developing Drugs, Journal of Advances in Pharmacoepidemiology & Drug Safety and Journal of Clinical Trials
    The Organizers reserve the rights to make changes and adjustment to the information in this website
    Copyright 2008-2012 OMICS Group - All rights reserved
    Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version